Fidasimtamab
Cat. No.: IBDI-431829
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity.
Product Details
| Target |
EGFR | PD-1/PD-L1 |
| Appearance |
Liquid |
| Synonyms |
IBI-315, BH2950 |
| Purity |
95.00% |
Storage & Handling
| Shipping |
Shipping with dry ice. |
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.
